Back
Editas Medicine Vs. Regencell Bioscience Holdings Industry Stock Comparison
Sell
21
EDIT
Editas Medicine
Last Price:
$1.29
Seasonality Move:
2.34%
Sell
39
RGC
Regencell Bioscience Holdings
Last Price:
$29.00
Seasonality Move:
12.6%
Sell
21
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $1.28. The Score for EDIT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $29.12. The Score for RGC is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $1.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight buying pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $29.12The current trend is moderately bullish and RGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
EDIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 49.43 | Sell |
| Chaikin Money Flow: | 54529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.12 - 1.38) | Buy |
| Bollinger Bands (100): | (1.12 - 1.94) | Sell |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.82 | Buy |
| Relative Strength Index (14 RSI): | 52.12 | Buy |
| Chaikin Money Flow: | 12946 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.9 - 40.58) | Sell |
| Bollinger Bands (100): | (-0.89 - 24.09) | Buy |
EDIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.22 | Buy |
| 20-day SMA: | 1.21 | Buy |
| 50-day SMA: | 1.45 | Sell |
| 200-day SMA: | 2.74 | Sell |
| 8-day EMA: | 1.24 | Buy |
| 20-day EMA: | 1.07 | Buy |
| 50-day EMA: | 0.69 | Buy |
| 200-day EMA: | 0.23 | Buy |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.47 | Sell |
| 20-day SMA: | 32.75 | Sell |
| 50-day SMA: | 18.13 | Buy |
| 200-day SMA: | 9.11 | Buy |
| 8-day EMA: | 30.17 | Sell |
| 20-day EMA: | 28.79 | Buy |
| 50-day EMA: | 21.65 | Buy |
| 200-day EMA: | 11.72 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Editas Medicine Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||